News
News from Holden
Filter by:
Burkard named director of UI Health Care Holden Comprehensive Cancer Center
After a national search, Mark Burkard, MD, PhD, has been selected to serve as director of Holden Comprehensive Cancer Center.
Student Spotlight: Laura Hovenga
Laura HovengaGrinnell, IowaSummer Cancer Undergraduate Research Program at Iowa, summer 2023
Faculty awarded 2024 ACS seed grant through Holden Comprehensive Cancer Center
Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Researc
Holden Researchers to Present New Cancer Research Data at 2024 AACR Annual Meeting
A total of 19 abstracts from University of Iowa and UI Holden Comprehensive Cancer Center researchers have been accep
Advice for all ages on colorectal cancer
More and more people across the country are finding themselves affected by colorectal ca
Melanoma vaccine trial to start at UI
Trial will test whether a personalized mRNA vaccine combined with an immunotherapy prevents melanoma from recurring
New radiation therapy targets tumors more precisely
Software piloted at UI Health Care increases precision of MR-Linac technology UI Health Care is the f
Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy
Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal Advanced Science.